Panacea Biotec Hits Lower Circuit After U.S. FDA Issues Warning Letter To Baddi Unit
An Ascophenum-P tablet sits before packaging at OAO Pharmstandard’s Leksredstva drug manufacturing unit in Kursk, Russia. (Photographer: Andrey Rudakov/Bloomberg)

Panacea Biotec Hits Lower Circuit After U.S. FDA Issues Warning Letter To Baddi Unit

Shares of Panacea Biotec Ltd. hit the lower circuit after the U.S. drug regulator issued a warning letter to its unit in Baddi, Himachal Pradesh, barring fresh approvals.The warning letter issued b...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.